Status:
COMPLETED
Home-based Assessment of PRO Measures in SCD Using A Smartphone App Platform: A Feasibility Study
Lead Sponsor:
Ann & Robert H Lurie Children's Hospital of Chicago
Conditions:
Sickle Cell Disease
Sickle Cell Hemoglobin C
Eligibility:
All Genders
12-25 years
Phase:
NA
Brief Summary
The overarching goal of this proposal is to identify modifiable behavioral strategies based on patient-reported outcomes (PROs) and health-related quality of life (HRQOL) that will improve hydroxyurea...
Detailed Description
Adherence to hydroxyurea is a multi-factorial dynamic process, and, to date, predictors for changes in adherence levels over time remain unclear. Changes in HRQOL data could serve as surrogate markers...
Eligibility Criteria
Inclusion
- Age 12 years or older at the time of study enrollment;
- SCD diagnosis (all genotypes) confirmed by hemoglobin electrophoresis;
- Own or have access to a smartphone or a tablet; and
- Speak and read English.
Exclusion
- Patients or caregivers with cognitive impairment;
- Patients or caregivers physical impairment; and
- Patients or caregivers who will not be able to complete study assessments.
Key Trial Info
Start Date :
April 4 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 21 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04678037
Start Date
April 4 2017
End Date
July 21 2019
Last Update
December 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States, 60611